4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001600132-17-000028
CIK 0001600132operating
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:23 PM ET
Size
4.5 KB
Accession
0001600132-17-000028
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Common Stock
2017-03-16+120,193→ 263,050 total
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:23 PM ET
- Size
- 4.5 KB